The Appropriations Committee of the U.S. House of Representatives has approved a $2 billion increase for the National Institutes of Health (NIH) and defeated an amendment that would have prohibited federal funding for fetal tissue research. The ISSCR supports all types of stem cell research, including fetal tissue research, and commends the committee’s action (8 May 2019).
“We are pleased the committee voted for a $2 billion budget increase for the NIH, which will allow for meaningful growth above inflation in the base budget and expand its capacity to support promising science and advance the development of new treatments,” said Doug Melton, ISSCR President. “We also support the rejection of an amendment to prohibit federal funding for fetal tissue research. This is a win for biomedical research and for patients awaiting development of new treatments. Fetal tissue remains critical for the development of potential new therapies in a number of areas including ALS, spinal cord injury, and Parkinson’s disease.”
In December 2018, the ISSCR coordinated and sent a letter to the US Department of Health and Human Services that explained the scientific importance of fetal tissue research. We also joined a coalition of scientific, academic, and patient groups in support of a $2.5 billion increase for the NIH.